Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O8TJ
|
|||
| Drug Name |
AR101
|
|||
| Synonyms |
5-[[(2R)-2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine; (R)-Iclaprim; CHEMBL1236788; 5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine; 5-{[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl}pyrimidine-2,4-diamine; SCHEMBL20138534; CHEBI:131752; XCF; ZINC3612862; BDBM50336513; DB08741; UNII-42445HUU0O component HWJPWWYTGBZDEG-AWEZNQCLSA-N
Click to Show/Hide
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Phase 3 | [1] | |
| Company |
Aimmune Therapeutics Brisbane, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22N4O3
|
|||
| Canonical SMILES |
COC1=C(C2=C(C=CC(O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC
|
|||
| InChI |
1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)/t14-/m0/s1
|
|||
| InChIKey |
HWJPWWYTGBZDEG-AWEZNQCLSA-N
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:131752
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.